A novel presentation of inappropriate antidiuretic hormone secretion in leigh syndrome with the myoclonic epilepsy and ragged red fibers, mitochondrial DNA 8344A>G mutation

Journal of Child Neurology

Volumn 25, Issue 6, 2010, Pages 782-785

  Swiderska, Nina ^a   Appleton, Richard ^a   Morris, Andrew ^b   Isherwood, David ^a   Selby, Andrew ^a  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Inappropriate antidiuretic hormone secretion; Leigh syndrome; Mitochondrial cytopathy; Mitochondrial DNA; Myoclonic epilepsy with ragged red fibers

Indexed keywords

ARGIPRESSIN; CYTOCHROME C OXIDASE; LYSINE TRANSFER RNA; MITOCHONDRIAL DNA; SODIUM; UBIDECARENONE; VASOPRESSIN;

ABNORMAL LABORATORY RESULT; ARTICLE; BRAIN STEM INJURY; CASE REPORT; CERVICAL SPINAL CORD INJURY; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; GENE MUTATION; HISTOCHEMISTRY; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INAPPROPRIATE VASOPRESSIN SECRETION; LEIGH DISEASE; MALE; MERRF SYNDROME; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA OSMOLARITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL;

DNA, MITOCHONDRIAL; FATAL OUTCOME; HUMANS; INFANT; LEIGH DISEASE; MAGNETIC RESONANCE IMAGING; MUTATION; VASOPRESSINS;

EID: 77952926538     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073809347594     Document Type: Article

References (12)

1. Debray FG, Lambert M., Chevalier I., et al. Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases. Pediatrics. 2007 ; 119 (4). 722-733.
2. Rahman S., Blok RB, Dahl HH, et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol. 1996 ; 39 (3). 343-351.
3. Huntsman RJ, Sinclair DB, Bhargava R., Chan A. Atypical presentations of Leigh syndrome: a case series and review. Pediatr Neurol. 2005 ; 32 (5). 334-340.
4. Schmiedel J., Jackson S., Schäfer J., Reichmann H. Mitochondrial cytopathies. J Neurol. 2003 ; 250 (3). 267-277.
5. Yasaki E., Saito Y., Nakano K., et al. Characteristics of breathing abnormality in Leigh and its overlap syndromes. Neuropediatrics. 2001 ; 32 (6). 299-306.
6. Santorelli FM, Tanji K., Shanske S., et al. The mitochondrial DNA A8344G mutation in Leigh syndrome revealed by analysis in paraffin-embedded sections: revisiting the past. Ann Neurol. 1998 ; 44 (6). 962-964.
7. Howell N., Kubacka I., Smith R., Frerman F., Parks JK, Parker WD Jr. Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease. Neurology. 1996 ; 46 (1). 219-222.
8. Silvestri G., Ciafaloni E., Santorelli FM, et al. Clinical features associated with the A→G transition at nucleotide 8344 of mtDNA ('MERRF mutationg'). Neurology. 1993 ; 43 (6). 1200-1206.
9. Zhang Y., Yang YL, Sun F., et al. Clinical and molecular survey in 124 Chinese patients with Leigh or Leigh-like syndrome. J Inherit Metab Dis. 2007 ; 30 (2). 265.
10. Tsao C., Herman G., Boue DR, et al. Leigh disease with mitochondrial DNA A8344G mutation: case report and brief review. J Child Neurol. 2003 ; 18 (1). 62-64.
11. Kubota H., Tanabe Y., Takanashi J., Kohno Y. Episodic hyponatraemia in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS). J Child Neurol. 2005 ; 20 (2). 116-120.
12. Southgate HJ, Penney MD Severe recurrent salt wasting in a boy with a mitochondrial oxidative phosphorylation defect. Ann Clin Biochem. 2000 ; 37 (pt 6). 805-808.